Literature DB >> 12012284

Continuous venovenous hemodiafiltration in neonatal onset hyperammonemia.

Takehiko Hiroma1, Tomohiko Nakamura, Masanori Tamura, Tsuyoshi Kaneko, Atsushi Komiyama.   

Abstract

We report on four cases of neonatal-onset hyperammonemia due to metabolic disorders treated with continuous hemodiafiltration (CHDF). CHDF accomplished prompt removal of serum ammonia under very stable circulation. To overcome the various difficulties of blood purification procedures to the neonate, we used: (1) a 7-Fr double lumen catheter from the internal jugular vein to the atrium to perform the procedure veno-venously, (2) a special circuit for neonates, (3) nafamostat mesilate as an anticoagulant, and (4) a circuit warmer. The serum ammonium level decreased under 200 microg/dL within 30 hours and lactic acidosis were corrected immediately. We conclude that CHDF is an extremely effective and safe treatment for fluminant neonatal-onset hyperammonemia due to metabolic disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12012284     DOI: 10.1055/s-2002-28487

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

1.  Hypothesis: proposals for the management of a neonate at risk of hyperammonaemia due to a urea cycle disorder.

Authors:  James Vivian Leonard; Martin Peter Ward Platt; Andrew Alan Myles Morris
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

2.  Multisite Retrospective Review of Outcomes in Renal Replacement Therapy for Neonates with Inborn Errors of Metabolism.

Authors:  Elizabeth G Ames; Corey Powell; Rachel M Engen; Donald J Weaver; Asif Mansuri; Michelle N Rheault; Keia Sanderson; Uta Lichter-Konecki; Ankana Daga; Lindsay C Burrage; Ayesha Ahmad; Scott E Wenderfer; Kera E Luckritz
Journal:  J Pediatr       Date:  2022-03-28       Impact factor: 6.314

3.  Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date?

Authors:  Ivana Pela; Daniela Seracini; Maria Alice Donati; Giancarlo Lavoratti; Elisabetta Pasquini; Marco Materassi
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

Review 4.  Role of artificial liver support in hepatic encephalopathy.

Authors:  V Stadlbauer; G A K Wright; R Jalan
Journal:  Metab Brain Dis       Date:  2008-12-21       Impact factor: 3.584

Review 5.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

Review 6.  Dialysis and pediatric acute kidney injury: choice of renal support modality.

Authors:  Scott Walters; Craig Porter; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2008-05-16       Impact factor: 3.714

7.  Renal replacement therapy for acute renal failure in children: European guidelines.

Authors:  Vladimirs Strazdins; Alan R Watson; Ben Harvey
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.